Cardiovascular Safety of Degarelix: Results From a 12-Month, Comparative, Randomized, Open Label, Parallel Group Phase III Trial in Patients With Prostate Cancer

✍ Scribed by Smith, Matthew R.; Klotz, Laurence; Persson, Bo-Eric; Olesen, Tine Kold; Wilde, Arthur A.M.

• Book ID: 122060203
• Publisher: Lippincott Williams and Wilkins
• Year: 2010
• Tongue: English
• Weight: 226 KB
• Volume: 184
• Category: Article
• ISSN: 0022-5347
• DOI: 10.1016/j.juro.2010.08.012